Aktis Oncolgy

Eli Lilly pays Aktis $60M upfront to further dial into radiopharma signal
Fierce Biotech
Tue, 05/21/24 - 11:13 am
Eli Lilly
Aktis Oncolgy
radiopharmaceuticals